- Message from the Director
- Chair, Board of Governors Message
- Board of Governors
- Leadership
- Sylvester Locations
- Sylvester by the Numbers
-
-
- Sylvester Researchers Receive $9.5 Million Grant To Study Esophageal Cancer
- NCI To Fund Sylvester-Led Study On How Exercise And Nutrition May Improve Ovarian Cancer Outcomes
- Researchers At Sylvester, Frost School Receive $2.6M Federal Grant To Study Mindfulness And Music Therapy
- Tow Foundation Commits $2 Million To Multiple Myeloma Research At Sylvester
- Sylvester Researchers Receive $2M To Conduct Clinical Trial On Unique Immunotherapy
- $1.8 Million NIH Grant Supports Head And Neck Cancer Research
- Sylvester Researchers Receive $1.7 Million NIH Grant To Study Epigenetic Mechanisms In ER Breast Cancer
- New Research Highlights Racial Disparities In Genomic Profiling
- Partnership To Identify Novel Genetic Drivers Of Cancer Disparities In African Ancestry Populations
- Our Phase 1 Clinical Trials
- Investigator-Initiated Trials (IIT)
- The Lifestyle Intervention Of Food And Exercise For Lymphoma – The LIFE-L Study
-
- Sylvester Partners With PAHO WHO To Train Caribbean Clinicians In Mammography Quality Assurance
- Sylvester Rectal Cancer Program Receives Elite NAPRC Accreditation From American College Of Surgeons
- The Lancet Publishes Sylvester-LED Study Defining New Standard Of Care For Prostate Cancer Recurrence After Prostatectomy
- Sylvester Plays Pivotal Role In Practice-Changing Anal Cancer Prevention Study Published By Nejm
- Dr. Donald T. Weed Works To Bridge Global Disparities In Head And Neck Surgery, From Haiti To Africa
-
- Paving The Path To Greatness: A Decade Of Transformation And Commitment To Excellence Celebration Honors Dr. Dipen J. Parekh And Dr. Stephen D. Nimer
- Dr. Antonio Iavarone Joins Sylvester As New Deputy Director
- Dr. Alberto Caban-Martinez Joins Prestigious Occupational And Environmental Health Organization
- Sylvester Names Dr. Sophia George To Lead The Cancer Center’s Focus On Diversity, Equity, And Inclusion
- Sylvester Researcher Receives $5 Million NCI Merit Award For Brain Cancer Adaptive Therapy Study
- Ph.D. Candidate At Sylvester Receives Prestigious F31 NCI Grant
- Sylvester’s Lead Of Evidence Based Survivorship Supportive Care Receives ABMR Early-Stage Investigator Award
- Neurosurgeon Ashish Shah Returns To Sylvester To Head Clinical Trials And Translational Research On Brain Tumors
- Sylvester Pancreatic Cancer Researcher Dr. Nagaraj Nagathihalli Awarded Florida Department Of Health Grant
- Scott M. Welford, Ph.D. And Dr. Priyamvada Rai To Co-Lead Sylvester’s Tumor Biology
- Employees Who Go Above And Beyond At Sylvester Earn Special Recognition
-
- Surviving And Thriving
- Sylvester Goes To Capitol Hill In Support Of Comprehensive Cancer Survivorship Act
- Sylvester’s Sexual Health After Cancer Program Expands To Meet Needs Of Women With Cancer
- Sylvester Celebrates Inaugural Cancer Survivorship Symposium
- Young Cancer Survivors Share Experiences, Support At Sylvester’s Aya Summit
- Testicular Cancer Patient, Against All Odds, Is Now A Father
- New “Believe In You” Training Program To Help Cancer Survivors Live A Healthier Lifestyle
- Art Is Medicine
- Spreading The Holiday Spirit To Children At Alex´s Place
- Cancer Support by the Numbers
-
- First Lady Jill Biden Visits Sylvester Comprehensive Cancer Center To Spread Breast Cancer Awareness
- Sylvester Leaders Meet With White House Officials, Agencies About Reducing Cancer
- Sylvester Game Changer Vehicle Among First In Nation To Offer Mobile Prostate Cancer Screening
- Sylvester Hosts Fourth Annual National Firefighter Cancer Symposium
- Florida Academic Cancer Center Alliance Brings Cancer Researchers Together During Annual Retreat
- Sylvester Researchers Identify High Death Rate From Gastric Cancer In South Florida
-
- Dolphins Challenge Cancer XII Raised Record-Breaking $8.4 Million For Sylvester
- Steeped In Tradition And Ceremony
- Sylvester’s 30th Naming Anniversary Celebration Honors Family’s Philanthropy And Foresight
- The Pap Corps Celebrated 70th Anniversary Supporting Cancer Research
- Gift Establishes Eileen Youtie Predisposition Syndrome Initiative At Sylvester
- Janet And Mark Levy Recognized For Gift To Advance Cancer And Neurology Research
- Honoring A Promise
- Jernigan Family Funds Research And Therapy At Sylvester
- Our Donors in 2022
ANCHOR study is likely to establish a new standard of care for people living with HIV.
Findings from the ANCHOR study that has screened 10,723 people living with HIV (PLHIV) and enrolled 4,446 from 25 U.S. sites, including Sylvester and Jackson Memorial Hospital, show that treating anal high-grade squamous intraepithelial lesions (HSIL), which are potentially precancerous, significantly lowers the risk of anal cancer compared to taking a wait-and-see approach.
The risk of anal cancer is higher among PLHIV than in the general population. And anal cancer is biologically similar to cervical cancer in the sense that both are caused by HPV and preceded by HSIL, according to Isabella Rosa Cunha, M.D., principal investigator of the ANCHOR study sites at Sylvester and Jackson Memorial Hospital and associate professor of medicine at the Miller School.
Investigators studied PLHIV 35 years and older with biopsies showing that they had anal HSIL. Subjects were randomized to either a treatment group, in which their lesions were treated mainly with electrocauterization, or an active monitoring group, without treatment.
During the study, nine cases of anal cancer were diagnosed among the 2,227 treated participants, compared with 21 cases of cancer among the 2,219 participants in the active monitoring group. The incidence of anal cancer was about 60% lower in the treatment arm, which is a significant finding.
This study will likely improve anal cancer prevention in other high-risk groups, including HIV-negative men who have sex with men, transplant patients, and women with HPV vulvar disease, according to Dr. Rosa-Cunha. The National Cancer Institute, which funded the study, has approved the study to continue to follow these patients until 2025.